Sana Biotechnology (SANA)

• Market cap: $873M
• 1 day: -2.68%
• 5 days: -3.25%
• 1 month: -15.06%
• 3 months: -34.6%
• 6 months: 5.48%
• Year to date: -21.96%
• 1 year: 18.05%
• 5 years: -88.98%
• 10 years: -90.68%
• Sector: Healthcare
• Industry: Biotechnology

About: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Employees: 142